Zhiying Luo

1.0k total citations
40 papers, 717 citations indexed

About

Zhiying Luo is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Zhiying Luo has authored 40 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Pharmacology. Recurrent topics in Zhiying Luo's work include Pharmacogenetics and Drug Metabolism (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Gut microbiota and health (4 papers). Zhiying Luo is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Gut microbiota and health (4 papers). Zhiying Luo collaborates with scholars based in China, United States and Malaysia. Zhiying Luo's co-authors include Jiecan Zhou, Bao Sun, Jian‐Quan Luo, Wenhui Liu, Wei Zhang, Xiaoping Chen, Bao Sun, Mouze Liu, Hong‐Hao Zhou and Bao Sun and has published in prestigious journals such as Nature Communications, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Zhiying Luo

36 papers receiving 710 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhiying Luo China 16 236 149 138 86 76 40 717
Jian‐Quan Luo China 17 213 0.9× 200 1.3× 97 0.7× 108 1.3× 55 0.7× 42 709
Huaijun Zhu China 16 197 0.8× 99 0.7× 87 0.6× 113 1.3× 39 0.5× 60 772
Zhonggao Xu China 17 312 1.3× 126 0.8× 116 0.8× 44 0.5× 204 2.7× 48 1.0k
M Hroch Czechia 20 198 0.8× 259 1.7× 63 0.5× 129 1.5× 79 1.0× 70 1.0k
Thomas J. Velenosi Canada 19 417 1.8× 158 1.1× 77 0.6× 140 1.6× 94 1.2× 31 973
Stephen Stewart Ireland 21 276 1.2× 91 0.6× 365 2.6× 108 1.3× 80 1.1× 46 1.8k
Abhijit Barve United States 14 108 0.5× 221 1.5× 67 0.5× 74 0.9× 148 1.9× 37 663
Sooyoung Shin South Korea 16 223 0.9× 119 0.8× 182 1.3× 63 0.7× 33 0.4× 58 947
Ziqi Tao China 9 356 1.5× 229 1.5× 109 0.8× 24 0.3× 75 1.0× 14 940
Daqing Zhang China 15 314 1.3× 65 0.4× 68 0.5× 56 0.7× 159 2.1× 37 836

Countries citing papers authored by Zhiying Luo

Since Specialization
Citations

This map shows the geographic impact of Zhiying Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiying Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiying Luo more than expected).

Fields of papers citing papers by Zhiying Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhiying Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiying Luo. The network helps show where Zhiying Luo may publish in the future.

Co-authorship network of co-authors of Zhiying Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Zhiying Luo. A scholar is included among the top collaborators of Zhiying Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhiying Luo. Zhiying Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Wenwen, et al.. (2025). Research progress on photodiscoloration mechanism and functional regulation in wood. Progress in Organic Coatings. 208. 109532–109532.
2.
Zhu, Yajun Emily, Wenhui Liu, Zhiying Luo, Feifei Xiao, & Bao Sun. (2024). New insights into the roles of lactylation in cancer. Frontiers in Pharmacology. 15. 1412672–1412672. 7 indexed citations
3.
Liu, Wenhui, Zhiying Luo, Yiping Liu, & Bao Sun. (2023). Current landscape and tailored management of immune-related adverse events. Frontiers in Pharmacology. 14. 1078338–1078338. 4 indexed citations
4.
Zou, You, Weiquan Wang, Junhong Chen, et al.. (2023). Gut microbial structural variation associates with immune checkpoint inhibitor response. Nature Communications. 14(1). 7421–7421. 29 indexed citations
5.
Ren, Huan, Huiqing Chen, Wenhui Liu, et al.. (2023). Multidimensional evaluation of teaching strategies for pharmacology based on a comprehensive analysis involving 21,269 students. Frontiers in Pharmacology. 14. 1145456–1145456. 12 indexed citations
6.
Liu, Wenhui, et al.. (2022). Durvalumab-Induced Demyelinating Lesions in a Patient With Extensive-Stage Small-Cell Lung Cancer: A Case Report. Frontiers in Pharmacology. 12. 799728–799728. 1 indexed citations
8.
Liu, Wenhui, Zhiying Luo, Jiecan Zhou, & Bao Sun. (2022). Gut Microbiota and Antidiabetic Drugs: Perspectives of Personalized Treatment in Type 2 Diabetes Mellitus. Frontiers in Cellular and Infection Microbiology. 12. 853771–853771. 44 indexed citations
9.
Sun, Bao, Zhiying Luo, & Jiecan Zhou. (2021). Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications. Cardiovascular Diabetology. 20(1). 9–9. 102 indexed citations
10.
Luo, Zhiying, et al.. (2021). Effect of NPC1L1 polymorphism on warfarin stable dose in Chinese patients under heart valve replacement surgery. Clinical and Experimental Pharmacology and Physiology. 49(2). 212–218.
11.
Liu, Wenhui, Yiping Liu, Fang Ma, et al.. (2021). Peripheral Blood Markers Associated with Immune-Related Adverse Effects in Patients Who Had Advanced Non-Small Cell Lung Cancer Treated with PD-1 Inhibitors. Cancer Management and Research. Volume 13. 765–771. 33 indexed citations
13.
Li, Dan, Zhiying Luo, Yi Chen, et al.. (2020). LRP1 and APOA1 Polymorphisms: Impact on Warfarin International Normalized Ratio-Related Phenotypes. Journal of Cardiovascular Pharmacology. 76(1). 71–76. 2 indexed citations
14.
Luo, Zhiying, Yi Zheng, & Wei Zhang. (2018). Pleiotropic functions of miR107 in cancer networks. OncoTargets and Therapy. Volume 11. 4113–4124. 15 indexed citations
15.
Yu, Jing, Lihua Zhang, Zhiying Luo, et al.. (2018). Relationship between polymorphisms of the lipid metabolism-related gene PLA2G16 and risk of colorectal cancer in the Chinese population. Functional & Integrative Genomics. 19(2). 227–236. 3 indexed citations
17.
Wang, Chunyang, et al.. (2018). Association between polymorphisms in <em>SLC15A1</em> and <em>PLA2G16 </em>genes and development of obesity in Chinese subjects. Diabetes Metabolic Syndrome and Obesity. Volume 11. 439–446. 2 indexed citations
18.
Liu, Mouze, Yueli Zhang, HU Yong-fang, et al.. (2017). IL-3 and CTLA4 gene polymorphisms may influence the tacrolimus dose requirement in Chinese kidney transplant recipients. Acta Pharmacologica Sinica. 38(3). 415–423. 24 indexed citations
19.
Sun, Bao, Lei Hu, Zhiying Luo, et al.. (2016). DNA methylation perspectives in the pathogenesis of autoimmune diseases. Clinical Immunology. 164. 21–27. 51 indexed citations
20.
He, Fazhong, Jian‐Quan Luo, Zhiying Luo, et al.. (2013). The KCNH2 Genetic Polymorphism (1956, C>T) Is a Novel Biomarker That Is Associated with CCB and α,β-ADR Blocker Response in EH Patients in China. PLoS ONE. 8(4). e61317–e61317. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026